Citations

Showing 10 of 108083 citations.

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
Neal, Matthew L., Beier, Eric E., Hossain, Muhammad M. , Boyle, Alexa, Kim, CK , Mhatre‐Winters, Isha , Wu, Long‐Jun , Kim, Chunki , Mhatre-Winters, Isha , Wu, Long-Jun , Neal, Matthew P, Boyle, Alexa M., Zheng, Jiaying , Richardson, Jason R.

Mayo Clinic

Antioxidants | February 27, 2023 | Volume: 12 | Issue: 3 | Pages: 582

10.3390/antiox12030582 | PMID 36978830 Get It

Although the precise mechanisms for neurodegeneration in Parkinson’s disease (PD) are unknown, evidence suggests that neuroinflammation is a critical factor in the pathogenic process. Here, we sought to determine whether the voltage-gated proton channel, Hv1 (HVCN1), which is expressed in microglia and regulates NADPH oxidase, is associated with dopaminergic neurodegeneration. We utilized data mining to evaluate the mRNA expression of HVCN1 in the brains of PD patients and controls and uncovered increased expression of the gene encoding Hv1, HVCN1, in the brains of PD patients compared to controls, specifically in male PD patients. In an acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 4 × 16 mg/kg) mouse model of PD, Hvcn1 gene expression was increased 2-fold in the striatum. MPTP administration to wild-type (WT) mice resulted in a ~65% loss of tyrosine hydroxylase positive neurons (TH+) in the substantia nigra (SN), while a ~39% loss was observed in Hv1 knockout (KO) mice. Comparable neuroprotective effects of Hv1 deficiency were found in a repeated-dose LPS model. Neuroprotection was associated with decreased pro-inflammatory cytokine levels and pro-oxidant factors in both neurotoxicant animal models. These in vivo results were confirmed in primary microglial cultures, with LPS treatment increasing Hvcn1 mRNA levels and Hv1 KO microglia failing to exhibit the LPS-mediated inflammatory response. Conditioned media from Hv1 KO microglia treated with LPS resulted in an attenuated loss of cultured dopamine neuron cell viability compared to WT microglia. Taken together, these data suggest that Hv1 is upregulated and mediates microglial pro-inflammatory cytokine production in parkinsonian models and therefore represents a novel target for neuroprotection.
Delayed open treatment of aortic penetration by a thoracic pedicle screw: illustrative case
Hobson, Sandra L. , Yaszemski, Michael J. , Levy, Hannah A. , Pinter, Zachariah W.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | February 27, 2023 | Volume: 5 | Issue: 9 | Pages: No page available

10.3171/case22533 | PMID 36852772 Get It

BACKGROUND Iatrogenic aortic injury from pedicle screw malpositioning or anterior prominence in posterior spinal fusion represents a rare but potentially devasting complication. While intraoperative aortic injury is associated with hemodynamic instability, delayed presentations of pedicle screw aortic impingement or violation often present insidiously with pseudoaneurysm or vascular remodeling in clinically asymptomatic patients. Currently, there is a lack of guidance in the field for the recommended surveillance, urgency of operative intervention, and optimal surgical management of delayed pedicle screw aortic injuries. OBSERVATIONS The following case study discusses the open treatment of delayed thoracic aortic penetration from an excessively long T12 pedicle screw in an asymptomatic adolescent patient with idiopathic scoliosis. The pedicle screw prominence anteriorly was corrected by burring the screw tip until it was flush with the vertebral body. The associated aortic injury was addressed with open vascular repair via primary anastomosis supplemented with a bovine pericardial patch. LESSONS Complete aortic wall penetration from an excessively long thoracic pedicle screw with otherwise stable screw positioning may be addressed most effectively with a single anterior surgical approach for open aortic repair and screw tip burring.
Anaplastic diffuse large B-cell lymphoma: a deceptive morphology
Sivasubramaniam, Priyadharshini , Ravindran, Aishwarya , Ravindran, Aishwarya

Mayo Clinic

Blood Research | February 27, 2023 | Volume: 58 | Issue: 1 | Pages: 1-1

10.5045/br.2023.2022247 | PMID 36843377 Get It

Laryngeal Imaging Study of Glottal Attack/Offset Time in Adductor Spasmodic Dysphonia during Connected Speech
Naghibolhosseini, Maryam , Zacharias, Stephanie R. C. , Zenas, Sarah, Levesque, Farrah, Deliyski, Dimitar D. , Naghibolhosseini, Maryam

Mayo Clinic

Applied Sciences | February 27, 2023 | Volume: 13 | Issue: 5 | Pages: 2979

10.3390/app13052979 | PMID 37034315 Get It

Adductor spasmodic dysphonia (AdSD) disrupts laryngeal muscle control during speech and, therefore, affects the onset and offset of phonation. In this study, the goal is to use laryngeal high-speed videoendoscopy (HSV) to measure the glottal attack time (GAT) and glottal offset time (GOT) during connected speech for normophonic (vocally normal) and AdSD voices. A monochrome HSV system was used to record readings of six CAPE-V sentences and part of the “Rainbow Passage” from the participants. Three raters visually analyzed the HSV data using a playback software to measure the GAT and GOT. The results show that the GAT was greater in the AdSD group than in the normophonic group; however, the clinical significance of the amount of this difference needs to be studied further. More variability was observed in both GATs and GOTs of the disorder group. Additionally, the GAT and GOT time series were found to be nonstationary for the AdSD group while they were stationary for the normophonic voices. This study shows that the GAT and GOT measures can be potentially used as objective markers to characterize AdSD. The findings will potentially help in the development of standardized measures for voice evaluation and the accurate diagnosis of AdSD.
Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review
Severseike, Benjamin O. , Schafernak, Kristian T. , Willard, Scott, Kothari, Alok , Eshun, Francis K., Mangum, Ross , Willard, Scott D, Gonçalves, Luís F. , Kothari, Alok K, Mangum, Ross , Schafernak, Kristian

Mayo Clinic

Journal of Clinical Laboratory Analysis | February 27, 2023 | Volume: 37 | Issue: 4 | Pages: No page available

10.1002/jcla.24854 | PMID 36843202 Get It

AbstractBackgroundRenal medullary carcinoma (RMC) is a diagnostically challenging, aggressive primary renal malignancy associated with abysmal survival. Delays in diagnosis contribute to most patients having diffusely metastatic disease at the time of initial presentation.MethodsWe present the case of a 13‐year‐old African American male with sickle cell trait who presented with a renal mass and hematuria. Evaluation included imaging, fluid cultures, and cytologic assessment.ResultsPatient was diagnosed with RMC based on cytologic assessment of sub‐centimeter fluid collections aspirated from the left kidney at the time of cortical biopsy for suspected renal mass. The additional fluid aspiration in conjunction with renal biopsy was an atypical but crucial step in early diagnosis.ConclusionCytomorphologic evaluation of fluid biospecimens is not currently part of the standard work‐up for patients with renal masses but, when available, can provide crucial information that reduces time to diagnosis. Prompt symptom recognition and treatment initiation may improve patient outcomes.
Dynamic NIR Fluorescence Imaging and Machine Learning Framework for Stratifying High vs. Low Notch-Dll4 Expressing Host Microenvironment in Triple-Negative Breast Cancer
Shafiee, Shayan , Jagtap, Jaidip , Zayats, Mykhaylo , Epperlein, Jonathan P. , Banerjee, Anjishnu , Geurts, Aron M. , Flister, Michael J. , Zhuk, Sergiy , Epperlein, Jonathan , Shafiee, Shayan , Banerjee, Anjishnu , Joshi, Amit

Mayo Clinic

Cancers | February 27, 2023 | Volume: 15 | Issue: 5 | Pages: 1460

10.3390/cancers15051460 | PMID 36900252 Get It

Delta like canonical notch ligand 4 (Dll4) expression levels in tumors are known to affect the efficacy of cancer therapies. This study aimed to develop a model to predict Dll4 expression levels in tumors using dynamic enhanced near-infrared (NIR) imaging with indocyanine green (ICG). Two rat-based consomic xenograft (CXM) strains of breast cancer with different Dll4 expression levels and eight congenic xenograft strains were studied. Principal component analysis (PCA) was used to visualize and segment tumors, and modified PCA techniques identified and analyzed tumor and normal regions of interest (ROIs). The average NIR intensity for each ROI was calculated from pixel brightness at each time interval, yielding easily interpretable features including the slope of initial ICG uptake, time to peak perfusion, and rate of ICG intensity change after reaching half-maximum intensity. Machine learning algorithms were applied to select discriminative features for classification, and model performance was evaluated with a confusion matrix, receiver operating characteristic curve, and area under the curve. The selected machine learning methods accurately identified host Dll4 expression alterations with sensitivity and specificity above 90%. This may enable stratification of patients for Dll4 targeted therapies. NIR imaging with ICG can noninvasively assess Dll4 expression levels in tumors and aid in effective decision making for cancer therapy.
Select Congenital Heart Disease: Important Echocardiographic Features and Changes during Pregnancy
Majdalany, David , Marcotte, François , Majdalany, David S

Mayo Clinic

Reviews in Cardiovascular Medicine | February 27, 2023 | Volume: 24 | Issue: 3 | Pages: No page available

10.31083/j.rcm2403066 | PMID 39077484 Get It

Congenital heart disease (CHD), which affects 1% to 2% of all births, is the most common abnormality in women contemplating pregnancy in western countries. With diagnostic and interventional advances, most patients with CHD survive into adulthood and require lifelong cardiac follow-up with cardiac imaging, particularly echocardiography and cardiac computed tomography. Multiple hemodynamic and physiologic changes of pregnancy may predispose patients with CHD to clinical decompensation and an inability to tolerate pregnancy. This manuscript reviews common CHD lesions, their repair or palliative interventions, long-term sequelae, important features to assess on cardiac imaging, and the impact of pregnancy on these types of lesions. Moreover, the review bridges the fields of CHD, cardiac imaging, and maternal cardiology, which will aid clinicians in counseling patients and managing pregnancies.
Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients
Geltzeiler, Mathew , Ji, Keven Seung Yong , JessMace, C., Almeida, John R. de , Champagne, Pierre‐Olivier , Chan, Erik, Ciporen, Jeremy , Chaskes, Mark B., Cornell, Sarah, Drozdowski, Veronica , Fernandez‐Miranda, Juan C. , Gardner, Paul A. , Hwang, Peter H. , Kalyvas, Aristotelis , Kong, Keonho A., McMillan, Ryan A. , Patel, Chirag , Patel, Zara M. , Celda, María Peris, Sanusi, Olabisi , Thorp, Brian D. , Zadeh, Gelareh , Zenonos, Georgios A. , Zwagerman, Nathan T. , Choby, Garret , Almeida, João Paulo , McMillan, Ryan A , Nayak, Jayakar V , Patel, Zara , Pinheiro-Neto, Carlos, Snyderman, Carl H , Wang, Eric W , Hwang, Peter H , Geltzeiler, Mathew , Choby, Garret , Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Gompel, Jamie J. Van

Mayo Clinic

International Forum of Allergy & Rhinology | February 26, 2023 | Volume: 13 | Issue: 10 | Pages: 1876-1888

10.1002/alr.23145 | PMID 36841933 Get It

AbstractBackgroundTraditional management of olfactory neuroblastoma (ONB) includes margin‐negative resection with removal of cribriform plate, dura, and olfactory bulb, regardless of intracranial disease. This approach may be overtreating certain patients. Our investigation examines risk factors associated with occult intracranial disease to optimize therapeutic outcomes.MethodsThis retrospective, multi‐institutional cohort study examined clinical covariates associated with occult intracranial involvement. Patient demographics, staging, Hyam's grade, and pathologic involvement of dura, olfactory bulb/tract, and brain were collected. Diagnostic imaging was reviewed. Positive and negative predictive value (NPV) were estimated along with effect size estimates. Cox hazard regression examined associations with overall survival (OS) and disease‐free survival (DFS).ResultsA total of 224 subjects with new diagnoses of ONB (2005–2021) were identified. Skull base bone involvement on computed tomography (CT) had the highest NPV for pathologic dura (88.0%), olfactory bulb (88%), and brain involvement (97.3%). Hyam's grade category was significantly associated with dural involvement (φC = 0.26; 95% confidence interval [CI]: 0.16, 0.42). Subjects without radiologic skull base involvement (n = 66) had pathologic positivity of 12.1%. Within this subgroup, Hyam's grade was clinically significant for dural positivity (φ = 0.34; 95% CI: −0.12, 0.71) with 28.6% involvement in high grade tumors. Neither clinical nor pathologic positivity of intracranial structures were associated with significantly different OS or DFS.ConclusionsBoth CT and magnetic resonance imaging (MRI) had reasonably good NPV for involvement of dura and olfactory bulb. Higher Hyam's grade was associated with dural involvement. Patients with low‐grade tumors not involving the skull base may be suitable for avoiding skull base resection; however, further investigation is warranted.
Synergistic interactions of obesity with sex, education, and smoking and accumulation of multi-morbidity (MM) across the lifespan
Chamberlain, Alanna M. , Kapoor, Ekta , Rocca, Walter A. , St Sauver, Jennifer L , Grossardt, Brandon R. , Chamberlain, Alanna M , Rocca, Walter A , Sauver, Jennifer L. St. , Kapoor, Ekta

Mayo Clinic

Journal of Multimorbidity and Comorbidity | February 25, 2023 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/26335565231160139 | PMID 36860667 Get It

Objectives Obesity is a potentially modifiable risk factor that has been consistently associated with the development and progression of multi-morbidity (MM). However, obesity may be more problematic for some persons compared to others because of interactions with other risk factors. Therefore, we studied the effect of interactions between patient characteristics and overweight and obesity on the rate of accumulation of MM. Methods We studied 4 cohorts of persons ages 20-, 40-, 60-, and 80-years residing in Olmsted County, Minnesota between 2005 and 2014 using the Rochester Epidemiology Project (REP) medical records-linkage system. Body mass index, sex, race, ethnicity, education, and smoking status were extracted from REP indices. The rate of accumulation of MM was calculated as the number of new chronic conditions accumulated per 10 person years through 2017. Poisson rate regression models were used to identify associations between characteristics and rate of MM accumulation. Additive interactions were summarized using relative excess risk due to interaction, attributable proportion of disease, and the synergy index. Results Greater than additive synergistic associations were observed between female sex and obesity in the 20- and 40-year cohorts, between low education and obesity in the 20-year cohort (both sexes), and between smoking and obesity in the 40-year cohort (both sexes). Conclusions Interventions targeted at women, persons with lower education, and smokers who also have obesity may result in the greatest reduction in the rate of MM accumulation. However, interventions may need to focus on persons prior to mid-life to have the greatest effect.
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
Ragon, Brittany Knick , Shah, Meera , D’Souza, Anita , Estrada‐Merly, Noel, Gowda, Lohith , George, Gemlyn , Lima, Marcos de , Hashmi, Shahrukh K. , Kharfan‐Dabaja, Mohamed A. , Majhail, Navneet S. , Banerjee, Rahul , Saad, Ayman , Hildebrandt, Gerhard , Mian, Hira , Abid, Muhammad Bilal , Lekakis, Lazaros J. , Strouse, Christopher , Aljurf, Mahmoud , Vesole, David H. , Lee, Cindy H. , Pawarode, Attaphol , Miller, Kevin C. , Holmberg, Leona , Afrough, Aimaz , Solh, Melhem , Munshi, Pashna N. , Anderson, Larry D. , Wirk, Baldeep , Qazilbash, Muzaffar H. , Shah, Nina , Kumar, Shaji , Usmani, Saad Z. , Holmberg, Leona , Shah, Mithun V , de Lima, Marcos , Hashmi, Shahrukh K , Patel, Sagar , Nieto, Yago , Badawy, Sherif M , Dholaria, Bhagirathbhai R , Miller, Kevin C , Nishihori, Taiga , Anderson, Larry D , Kaur, Gurbakhash , Kumar, Shaji K , D'Souza, Anita , Saad, Ayman , Majhail, Navneet S , Banerjee, Rahul , Strouse, Christopher S , Mian, Hira , Usmani, Saad , Abid, Muhammad Bilal , Battiwalla, Minoo , Patel, Sagar S. , Murthy, Hemant S. , Nieto, Yago , Badawy, Sherif M. , Al Hadidi, Samer , Dholaria, Bhagirathbhai , Gergis, Usama , Nishihori, Taiga , Kaur, Gurbakhash

Mayo Clinic

Blood Advances | February 24, 2023 | Volume: 7 | Issue: 12 | Pages: 2746-2757

10.1182/bloodadvances.2022009138 | PMID 36827681 Get It

Abstract The overall survival (OS) has improved significantly in multiple myeloma (MM) over the last decade with the use of proteasome inhibitor and immunomodulatory drug-based combinations, followed by high-dose melphalan and autologous hematopoietic stem cell transplantation (auto-HSCT) and subsequent maintenance therapies in eligible newly diagnosed patients. However, clinical trials using auto-HSCT followed by lenalidomide maintenance have shown an increased risk of second primary malignancies (SPM), including second hematological malignancies (SHM). We evaluated the impact of SPM and SHM on progression-free survival (PFS) and OS in patients with MM after auto-HSCT using CIBMTR registry data. Adult patients with MM who underwent first auto-HSCT in the United States with melphalan conditioning regimen from 2011 to 2018 and received maintenance therapy were included (n = 3948). At a median follow-up of 37 months, 175 (4%) patients developed SPM, including 112 (64%) solid, 36 (20%) myeloid, 24 (14%) SHM, not otherwise specified, and 3 (2%) lymphoid malignancies. Multivariate analysis demonstrated that SPM and SHM were associated with an inferior PFS (hazard ratio [HR] 2.62, P < .001 and HR 5.01, P < .001, respectively) and OS (HR 3.85, P < .001 and HR 8.13, P < .001, respectively). In patients who developed SPM and SHM, MM remained the most frequent primary cause of death (42% vs 30% and 53% vs 18%, respectively). We conclude the development of SPM and SHM leads to a poor survival in patients with MM and is an important survivorship challenge. Given the median survival for MM continues to improve, continued vigilance is needed to assess the risks of SPM and SHM with maintenance therapy post–auto-HSCT.